A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer

NCT06165809 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The sponsor voluntarily withdraw the project.

Conditions

Advanced Malignant Neoplasm

Interventions

DRUG: TQB3015 tablets

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.